Chembio Diagnostics, Inc. (NASDAQ:CEMI) management will conduct a conference call for 5th November 2020 at 4:30 PM Eastern Time to discuss financial results and companys performance for 3Q20.
The conference call will also be available live on the website chembio.com
Earnings Expectation
Chembio Diagnostics, Inc. developer of diagnostic tests that detect infectious diseases, is reporting third quarter earnings results on Thursday 5th November 2020, after market close.
The consensus estimates from Thomson Reuters are loss of $ 0.26 per share from $ 3.91 million in revenue. For the full year, analysts predict revenues of $ 21.08 million, while looking forward to loss of $ 1.17 per share.
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for HIV and Syphilis, and Zika virus. It also develops tests for malaria, Dengue virus, chikungunya virus, ebola, lassa, marburg, leptospirosis, Rickettsia typhi, Burkholderia pseudomallei, and Orientia tsutsugamushi.
